Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Sign Up
Cited by 7

The DOI matches its Crossref record.

Combination of Tadalafil and Finasteride for the Treatment of Urinary Tract Symptoms Related to Benign Prostatic Hyperplasia: Commercialization of the Prescribing Cascade

Nguyen, David-Dan, Trinh, Quoc-Dien, Bhojani, Naeem·2022·European Urology
DOI 10.1016/j.eururo.2022.01.009
Open this paper in CoChat — free account

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.eururo.2022.01.009

Cites

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

No references could be resolved yet.

Research works printed but not linked: 9

  1. Casabé, 2014, Efficacy and safety of the coadministration of tadalafil once daily with finasteride for 6 months in men with lower urinary tract symptoms and prostatic enlargement secondary to benign prostatic hyperplasia, J Urol, 191, 727, 10.1016/j.juro.2013.09.059 · DOI
  2. Lerner, 2021, Management of lower urinary tract symptoms attributed to benign prostatic hyperplasia: AUA guideline part I—initial work-up and medical management, J Urol, 206, 806, 10.1097/JU.0000000000002183 · DOI
  3. Elkelany, 2015, Combination of tadalafil and finasteride for improving the symptoms of benign prostatic hyperplasia: critical appraisal and patient focus, Ther Clin Risk Manag, 11, 507, 10.2147/TCRM.S80353 · DOI · Paper page
  4. Gormley, 1992, The effect of finasteride in men with benign prostatic hyperplasia, N Engl J Med, 327, 1185, 10.1056/NEJM199210223271701 · DOI
  5. Rochon, 2017, The prescribing cascade revisited, Lancet, 389, 1778, 10.1016/S0140-6736(17)31188-1 · DOI
  6. Bhojani, 2021, Review of sexual preservation after novel benign prostatic hyperplasia surgical treatment modalities from Food and Drug Administration clinical trials, Sex Med Rev, 9, 169, 10.1016/j.sxmr.2020.09.003 · DOI
  7. Nguyen, 2021, Investigation of suicidality and psychological adverse events in patients treated with finasteride, JAMA Dermatol, 157, 35, 10.1001/jamadermatol.2020.3385 · DOI
  8. Papanicolas, 2018, Health care spending in the United States and other high-income countries, JAMA, 319, 1024, 10.1001/jama.2018.1150 · DOI · Paper page
  9. Malde, 2021, A systematic review of patients’ values, preferences, and expectations for the diagnosis and treatment of male lower urinary tract symptoms, Eur Urol, 79, 796, 10.1016/j.eururo.2020.12.019 · DOI

Cited by

Metadata

Authors
Nguyen, D.-D., Trinh, Q.-D., & Bhojani, N.
Venue
European Urology
Publisher
Elsevier BV
Published
2022-04
Volume
81
Issue
4
Pages
323-324
ISSN
0302-2838
DOI
10.1016/j.eururo.2022.01.009
Cited by
7
References
0
Language
en
Licence
  • www.elsevier.com/tdm/userlicense/1.0/ (tdm)
  • www.elsevier.com/legal/tdmrep-license (tdm)
Funders
  • Bayer
  • Pfizer
  • Astellas Pharma US

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.